2 Cancer research benefits large drug companies and nothing else
In 2009, an important analysis was published from the University of Michigan. It actually revealed how several cancer studies turned out false. The analysis gave the suggestion that results from such studies were fabricated for the benefit of drug companies which makes practical sense as most studies were funded by them.
Richard Houghton editor in chief of UK’s leading medical journal The Lancet remarked that “The case against science is straightforward: much of the scientific literature, perhaps maybe half, may simply be untrue. Science has taken a turn toward darkness.” Senior chemist for the national cancer institute, Biochemist Dean Burk more or less summed up the prevailing conditions in cancer research. He said that those in power don’t really have to speak the truth. Giant corporations have found a means to make more profits through deceit.
...[ Continue to next page ]
Share This Post
